• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

当代经皮冠状动脉介入治疗在老年人和极老年人中的结果:密歇根蓝十字蓝盾心血管联合会的见解。

Outcome of contemporary percutaneous coronary intervention in the elderly and the very elderly: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.

机构信息

Division of Cardiovascular Medicine, University of Michigan Medical School, Ann Arbor, Michigan 48109-5853, USA.

出版信息

Clin Cardiol. 2011 Sep;34(9):549-54. doi: 10.1002/clc.20926. Epub 2011 Jun 29.

DOI:10.1002/clc.20926
PMID:21717474
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6652312/
Abstract

BACKGROUND

There is a paucity of data on the outcome of contemporary percutaneous coronary intervention (PCI) in the elderly. Accordingly, we assessed the impact of age on outcome of a large cohort of patients undergoing PCI in a regional collaborative registry.

HYPOTHESIS

Increasing age is associated with a higher incidence of procedural-related complications.

METHODS

We evaluated the outcome of 152,373 patients who underwent PCI from 2003 to 2008 in the 31 hospitals participating in the Blue Cross Blue Shield of Michigan Cardiovascular Consortium. The procedural outcomes of the cohort were compared by dividing patients into < 70 years of age, 70 to 79 years, 80 to 84 years, 85 to 89 years, and ≥ 90 years.

RESULTS

Of the cohort, 64.64% were <70 years of age, 23.83% were 70 to 79 years, 7.85% were 80 to 84 years, 3.09% were 85 to 89 years, and 0.58% were 90 years or older. Increasing age was associated with an increase in all-cause in-hospital mortality, contrast-induced nephropathy, transfusion, stroke/transient ischemic attack, and vascular complications. The overall in-hospital mortality rate was 1.09% and increased from 0.67% in those younger than 70 years up to 5.44% in those 90 years old or greater. The mortality rate in patients over 80 years approached 12% to 15% for those with ST-segment myocardial infarction and 39% in cardiogenic shock patients.

CONCLUSIONS

The proportion of elderly patients referred for PCI is increasing. Procedural complications increase with age, and patients presenting with unstable symptoms are at the highest risk.

摘要

背景

目前关于当代经皮冠状动脉介入治疗(PCI)在老年人中的结果的数据很少。因此,我们评估了在一个区域性合作注册中心中,大量接受 PCI 的患者的年龄对结果的影响。

假设

年龄的增加与更高的与手术相关的并发症发生率相关。

方法

我们评估了 2003 年至 2008 年间在密歇根蓝十字蓝盾心血管联合会的 31 家医院参与的 PCI 患者 152373 例的结果。通过将患者分为<70 岁、70-79 岁、80-84 岁、85-89 岁和≥90 岁,比较了队列的手术结果。

结果

队列中 64.64%的患者<70 岁,23.83%的患者 70-79 岁,7.85%的患者 80-84 岁,3.09%的患者 85-89 岁,0.58%的患者 90 岁或以上。年龄的增加与全因住院死亡率、对比剂诱导的肾病、输血、卒中和短暂性脑缺血发作以及血管并发症的增加相关。总的住院死亡率为 1.09%,从<70 岁的 0.67%上升到 90 岁以上的 5.44%。80 岁以上患者的死亡率在 ST 段抬高型心肌梗死患者中接近 12%至 15%,在心源性休克患者中达到 39%。

结论

转诊接受 PCI 的老年患者比例在增加。手术并发症随年龄增加而增加,有不稳定症状的患者风险最高。

相似文献

1
Outcome of contemporary percutaneous coronary intervention in the elderly and the very elderly: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.当代经皮冠状动脉介入治疗在老年人和极老年人中的结果:密歇根蓝十字蓝盾心血管联合会的见解。
Clin Cardiol. 2011 Sep;34(9):549-54. doi: 10.1002/clc.20926. Epub 2011 Jun 29.
2
Underutilization of Radial Access in Patients Undergoing Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.密歇根蓝十字蓝盾心血管联盟对接受经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者桡动脉入路使用不足的见解。
Circ Cardiovasc Interv. 2015 May;8(5). doi: 10.1161/CIRCINTERVENTIONS.114.002036.
3
Retroperitoneal hematoma after percutaneous coronary intervention: prevalence, risk factors, management, outcomes, and predictors of mortality: a report from the BMC2 (Blue Cross Blue Shield of Michigan Cardiovascular Consortium) registry.经皮冠状动脉介入治疗后腹膜后血肿:患病率、危险因素、处理、结局和死亡率的预测因素:来自 BMC2(密歇根蓝十字蓝盾心血管联合会)注册研究的报告。
JACC Cardiovasc Interv. 2010 Aug;3(8):845-50. doi: 10.1016/j.jcin.2010.05.013.
4
Safety of contemporary percutaneous peripheral arterial interventions in the elderly insights from the BMC2 PVI (Blue Cross Blue Shield of Michigan Cardiovascular Consortium Peripheral Vascular Intervention) registry.当代经皮外周动脉介入治疗在老年人中的安全性:来自 BMC2 PVI(密歇根蓝十字蓝盾心血管联合会外周血管介入)注册研究的见解。
JACC Cardiovasc Interv. 2011 Jun;4(6):694-701. doi: 10.1016/j.jcin.2011.03.012.
5
The association of sex with outcomes among patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction in the contemporary era: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).在当代,对接受直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者进行的性别与结局的相关性分析:来自密歇根蓝十字蓝盾心血管联合会(BMC2)的见解。
Am Heart J. 2011 Jan;161(1):106-112.e1. doi: 10.1016/j.ahj.2010.09.030.
6
The epidemiology and outcomes of percutaneous coronary intervention before high-risk noncardiac surgery in contemporary practice: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) Registry.当代实践中高危非心脏手术前经皮冠状动脉介入治疗的流行病学及结果:来自密歇根蓝十字蓝盾心血管联盟(BMC2)注册研究的见解。
J Am Heart Assoc. 2014 May 12;3(3):e000388. doi: 10.1161/JAHA.113.000388.
7
Percutaneous Coronary Intervention for Chronic Total Occlusion-The Michigan Experience: Insights From the BMC2 Registry.经皮冠状动脉介入治疗慢性完全闭塞:密歇根经验:BMC2 注册研究的见解。
JACC Cardiovasc Interv. 2020 Jun 8;13(11):1357-1368. doi: 10.1016/j.jcin.2020.02.025. Epub 2020 May 13.
8
Outcomes After Percutaneous Coronary Intervention in Patients With a History of Cerebrovascular Disease: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.有脑血管病史患者经皮冠状动脉介入治疗的结果:密歇根蓝十字蓝盾心血管联合会的见解。
Circ Cardiovasc Interv. 2018 Jun;11(6):e006400. doi: 10.1161/CIRCINTERVENTIONS.118.006400.
9
Impact of pre-procedural beta blockade on inpatient mortality in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction.经皮冠状动脉介入治疗 ST 段抬高型心肌梗死患者术前β受体阻滞剂对住院死亡率的影响。
Am J Cardiol. 2013 Jun 15;111(12):1714-20. doi: 10.1016/j.amjcard.2013.02.022. Epub 2013 Mar 22.
10
Association of Operator and Hospital Experience With Procedural Success Rates and Outcomes in Patients Undergoing Percutaneous Coronary Interventions for Chronic Total Occlusions: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.在接受经皮冠状动脉介入治疗慢性完全闭塞病变的患者中,术者经验与医院经验与手术成功率及预后的关联:来自密歇根蓝十字蓝盾心血管联盟的见解
Circ Cardiovasc Interv. 2020 Aug;13(8):e008863. doi: 10.1161/CIRCINTERVENTIONS.119.008863. Epub 2020 Aug 14.

引用本文的文献

1
A Single Transradial Guiding Catheter in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention: A Door-to-Balloon Optimized Strategy.在接受经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者中使用单根桡动脉引导导管:一种门球时间优化策略。
Cureus. 2023 Oct 10;15(10):e46802. doi: 10.7759/cureus.46802. eCollection 2023 Oct.
2
A Newly Defined CHADS-VA Score for Predicting Obstructive Coronary Artery Disease in Patients with Atrial Fibrillation-A Cross-Sectional Study of Older Persons Referred for Elective Coronary Angiography.一种新定义的CHADS-VA评分用于预测心房颤动患者的阻塞性冠状动脉疾病——一项针对接受择期冠状动脉造影的老年人的横断面研究。
J Clin Med. 2022 Jun 16;11(12):3462. doi: 10.3390/jcm11123462.
3
A Comparison Between Two Definitions of Contrast-Associated Acute Kidney Injury for Long-Term Mortality in Elderly and Non-elderly Patients After Elective Percutaneous Coronary Intervention.选择性经皮冠状动脉介入治疗后老年和非老年患者中,两种对比剂相关性急性肾损伤定义对长期死亡率的比较
Front Cardiovasc Med. 2021 Sep 27;8:720857. doi: 10.3389/fcvm.2021.720857. eCollection 2021.
4
Outcomes of percutaneous coronary intervention for chronic total occlusions in the elderly: A systematic review and meta-analysis.老年患者经皮冠状动脉介入治疗慢性完全闭塞病变的结局:系统评价和荟萃分析。
Clin Cardiol. 2021 Jan;44(1):27-35. doi: 10.1002/clc.23524. Epub 2020 Dec 17.
5
Clinical outcomes of elderly South-East Asian patients in primary percutaneous coronary intervention for ST-elevation myocardial infarction.东南亚老年患者接受ST段抬高型心肌梗死直接经皮冠状动脉介入治疗的临床结果
J Geriatr Cardiol. 2016 Oct;13(10):830-835. doi: 10.11909/j.issn.1671-5411.2016.10.001.
6
Outcomes of percutaneous coronary intervention in patients ≥ 75 years: one-center study in a Chinese patient group.75岁及以上患者经皮冠状动脉介入治疗的结果:中国患者群体的单中心研究
J Geriatr Cardiol. 2015 Nov;12(6):626-33. doi: 10.11909/j.issn.1671-5411.2015.06.004.
7
Acute coronary syndrome in octogenarians: association between percutaneous coronary intervention and long-term mortality.八旬老人的急性冠状动脉综合征:经皮冠状动脉介入治疗与长期死亡率之间的关联。
Clin Interv Aging. 2015 Sep 28;10:1547-53. doi: 10.2147/CIA.S89127. eCollection 2015.
8
Incidence and risk of developing contrast-induced acute kidney injury following intravascular contrast administration in elderly patients.老年患者血管内注射造影剂后发生造影剂诱导的急性肾损伤的发生率及风险。
Clin Interv Aging. 2014;9:85-93. doi: 10.2147/CIA.S55157. Epub 2013 Dec 31.
9
Long-term prognostic impact of cystatin C on acute coronary syndrome octogenarians with diabetes mellitus.胱抑素C对患有糖尿病的急性冠状动脉综合征八旬老人的长期预后影响。
Cardiovasc Diabetol. 2013 Nov 1;12:157. doi: 10.1186/1475-2840-12-157.
10
B-type natriuretic peptides in acute coronary syndromes: implications in an aging population.B 型利钠肽在急性冠状动脉综合征中的作用:在老龄化人口中的意义。
Clin Cardiol. 2012 Nov;35(11):682-5. doi: 10.1002/clc.22035. Epub 2012 Jul 3.

本文引用的文献

1
Primary percutaneous coronary interventions in nonagenarians.对 90 岁以上老年人进行的直接经皮冠状动脉介入治疗。
Clin Cardiol. 2010 Mar;33(3):157-61. doi: 10.1002/clc.20720.
2
Trends in the association between age and in-hospital mortality after percutaneous coronary intervention: National Cardiovascular Data Registry experience.经皮冠状动脉介入治疗后年龄与住院死亡率相关性的变化趋势:国家心血管数据注册研究。
Circ Cardiovasc Interv. 2009 Feb;2(1):20-6. doi: 10.1161/CIRCINTERVENTIONS.108.826172. Epub 2009 Feb 10.
3
Percutaneous coronary interventions in nonagenarians: in-hospital mortality and outcome at one year follow-up.90 岁以上患者行经皮冠状动脉介入治疗:院内死亡率及一年随访预后。
Clin Cardiol. 2009 Dec;32(12):E16-21. doi: 10.1002/clc.20596.
4
Comparison of coronary revascularization procedures in octogenarians: a systematic review and meta-analysis.八旬老人冠状动脉血运重建手术的比较:一项系统评价和荟萃分析。
Nat Clin Pract Cardiovasc Med. 2008 Nov;5(11):738-46. doi: 10.1038/ncpcardio1348. Epub 2008 Sep 30.
5
Long-term outcome of patients of over 85 years old with acute coronary syndrome undergoing percutaneous coronary stenting: a comparison of bare metal stent and drug eluting stent.85岁以上急性冠脉综合征患者接受经皮冠状动脉支架置入术的长期预后:裸金属支架与药物洗脱支架的比较
Chin Med J (Engl). 2008 May 20;121(10):887-91.
6
An evaluation of octogenarians undergoing percutaneous coronary intervention from the Melbourne Interventional Group registry.来自墨尔本介入治疗组登记处的对接受经皮冠状动脉介入治疗的八旬老人的一项评估。
Catheter Cardiovasc Interv. 2007 Dec 1;70(7):928-36. doi: 10.1002/ccd.21303.
7
Results of percutaneous coronary interventions in patients > or =90 years of age.90岁及以上患者经皮冠状动脉介入治疗的结果。
Catheter Cardiovasc Interv. 2007 Dec 1;70(7):937-43. doi: 10.1002/ccd.21263.
8
Labor force participation and human capital increases in an aging population and implications for U.S. research investment.老龄化人口中劳动力参与率和人力资本的增长及其对美国研究投资的影响。
Proc Natl Acad Sci U S A. 2007 Jun 26;104(26):10802-7. doi: 10.1073/pnas.0704185104. Epub 2007 Jun 15.
9
Optimal medical therapy with or without PCI for stable coronary disease.稳定型冠心病接受或不接受经皮冠状动脉介入治疗的优化药物治疗
N Engl J Med. 2007 Apr 12;356(15):1503-16. doi: 10.1056/NEJMoa070829. Epub 2007 Mar 26.
10
Change in chronic disability from 1982 to 2004/2005 as measured by long-term changes in function and health in the U.S. elderly population.1982年至2004/2005年期间美国老年人口慢性残疾的变化情况,这是通过功能和健康状况的长期变化来衡量的。
Proc Natl Acad Sci U S A. 2006 Nov 28;103(48):18374-9. doi: 10.1073/pnas.0608483103. Epub 2006 Nov 13.